Department of Biotechnology

Department of Biotechnology

New Delhi, Delhidbtindia.gov.in

Overview

The Department of Biotechnology (DBT) is a department of the Indian government under the Ministry of Science and Technology, established in 1986. Its primary mandate is to promote and accelerate the development, commercialization, and application of biotechnology in India across sectors like healthcare, agriculture, and the environment. While its main role is that of a government body, it also functions as an investor by providing funding and support to startups, researchers, and companies. This is largely carried out through various grants, schemes, and its public sector enterprise, the Biotechnology Industry Research Assistance Council (BIRAC), which was set up by the DBT to strengthen and empower biotech enterprises.

Portfolio Companies

11

Investments

CompanyDateStageLead
Fibroheal WoundcareSep 2021VC RoundCo-investor
1Cell.AiJul 2021GrantCo-investor
Huwel LifesciencesMay 2020DebtCo-investor
Curadev PharmaApr 2016GrantLead
DF3DMar 2015GrantCo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersNew Delhi, Delhi
Year FoundedN/A

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.